StockData
NRX Pharmaceuticals, Inc. logo

NRX Pharmaceuticals, Inc. (NRXP) stock

NRXPNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 0/30
$2.80+0.35 (+14.29%)

Close on Nov 18, 2026Market cap $121.23MP/E –Yield –

NRX Pharmaceuticals revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

NRX Pharmaceuticals's revenue for the twelve months ending Jun 30, 2026 was $3.39M. For fiscal 2025 it was $1.23M.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.23M–
FY2024Dec 31, 2024$0–
FY2023Dec 31, 2023$0–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$1.10M–
Q1 FY2026Mar 31, 2026$1.07M–
Q4 FY2025Dec 31, 2025$983.00K–
Q3 FY2025Sep 30, 2025$242.00K–
Q2 FY2025Jun 30, 2025$0–
Q1 FY2025Mar 31, 2025$0–
Q4 FY2024Dec 31, 2024$0–
Q3 FY2024Sep 30, 2024$0–

More NRX Pharmaceuticals figures

See a number that looks wrong?